Oxygen Therapy for the Treatment of Experimental Autoimmune Encephalomyelitis
DOI:
https://doi.org/10.17140/SEMOJ-8-186Keywords:
Experimental autoimmune encephalomyelitis, Multiple sclerosis, Animal modelAbstract
Background
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS). Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of MS. Oxygen therapy, such as hyperbaric oxygen (HBO) or normobaric oxygen (NBO), has been advanced as a potential treatment option to allay the motor and sensory deficits associated with MS. However, it is unclear whether any therapeutic benefits derived from treatment are a result of pressurized oxygen or simply pure oxygen administration. This study aimed to explore whether pressurized oxygen (HBO) or sea-level oxygen (NBO) would attenuate the motor and sensory deficits associated with EAE.
Methods
Forty-two male Harlan Lewis rats were randomly assigned to one of four conditions: MBP/HBO, MBP/NBO, MBP/no treatment, or a vehicle group. Injections of MBP or vehicle were administered on day 1, and animals were allowed one-week to recover. Following recovery, animals were administered HBO at 2.0 atmospheres absolute (ATA) or sea-level oxygen for 60-minutes daily. Mechanical paw withdrawal threshold (MPWT) testing was conducted on the first day and every alternate day after the start of treatment to assess the development of tactile allodynia. Motor impairment tests were performed twice daily (immediately prior to and after oxygen treatment) to assess for the presence of motor deficits or paralysis.
Results
On days 14 through 18, animals injected with MBP had a greater level of motor impairment compared to the vehicle control group. Interestingly, results also indicated that NBO was as effective as HBO in attenuating EAE symptoms.
Conclusion
In conclusion, these results underscore the need for further research to determine the ideal parameters of oxygen treatment, particularly whether pressurization is necessary to attenuate symptoms of EAE.
References
Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experi-mental autoimmune encephalomyelitis (EAE) as a model for mul-tiple sclerosis (MS). Br J Pharmacol. 2011; 164(4): 1079-1106. doi: 10.1111/j.1476-5381.2011.01302.x Original Research | Volume 8 | Number 1 | Wilson JR, et al
Stanley NC, Jackson FL, Orr EL. Attenuation of experimen-tal autoimmune encephalomyelitis by Compound 48/80 in Lewis rats. J Neuroimmunol. 1990; 29(1-3): 223-228. doi: 10.1016/0165- 5728(90)90165-j
Wekerle H. Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease. Curr Opin Neurobiol. 1993; 3(5): 779-784. doi: 10.1016/0959-4388(93)90153-p
Wiśniewski HM, Keith AB. Chronic relapsing experimental al-lergic encephalomyelitis: An experimental model of multiple scle-rosis. Ann Neurol. 1977; 1(2): 144-148. doi: 10.1002/ana.410010207
Singhal AB, Wang X, Sumii T, Mori T, Lo EH. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab. 2002; 22(7): 861-868. doi: 10.1097/00004647-200207000-00011
Jain KK. Textbook of Hyperbaric Medicine. Cambridge, MA, USA: Hogrefe & Huber; 2004: 536.
Bosco G, Yang Z-j, Nandi J, Wang J, Chen C, Camporesi EM. Effects of hyperbaric oxygen on glucose, lactate, glycerol and anti-oxidant enzymes in the skeletal muscle of rats during ischaemia and reperfusion. Clin Exp Pharmacol Physiol. 2007; 34(1-2): 70-76. doi: 10.1111/j.1440-1681.2007.04548.x
Ohgami Y, Zylstra CC, Quock LP, Chung E, Shirachi DY, Quock RM. Nitric oxide in hyperbaric oxygen-induced acute antinocicep-tion in mice. Neuroreport. 2009; 20(15): 1325-1329. doi: 10.1097/ WNR.0b013e3283305a49
Thompson CD, Uhelski ML, Wilson JR, Fuchs PN. Hyperbaric oxygen treatment decreases pain in two nerve injury models. Neu-rosci Res. 2010; 66(3): 279-283. doi: 10.1016/j.neures.2009.11.010
Wilson HD, Toepfer VE, Senapati AK, Wilson JR, Fuchs PN. Hyperbaric oxygen treatment is comparable to acetylsalicylic acid treatment in an animal model of arthritis. J Pain. 2007; 8(12): 924- 30. doi: 10.1016/j.jpain.2007.06.005
Wilson HD, Wilson JR, Fuchs PN. Hyperbaric oxygen treat-ment decreases inflammation and mechanical hypersensitivity in an animal model of inflammatory pain. Brain Res. 2006; 1098(1): 126-128. doi: 10.1016/j.brainres.2006.04.088
Bigdeli MR, Khoshbaten A. In vivo preconditioning with nor-mobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/nuclear factor-kappaB. Neuroscience. 2008; 153(3): 671- 678. doi: 10.1016/j.neuroscience.2008.02.064
Bigdeli MR. Preconditioning with prolonged normobaric hy-peroxia induces ischemic tolerance partly by upregulation of an-tioxidant enzymes in rat brain tissue. Brain Res. 2009; 1260: 47-54. doi: 10.1016/j.brainres.2008.12.065
Bunc M, Luzar B, Finderle Z, Suput D, Brvar M. Immediate oxygen therapy prevents brain cell injury in carbon monoxide poi-soned rats without loss of consciousness. Toxicology. 2006; 225(2- 3): 138-141. doi: 10.1016/j.tox.2006.05.012
Shin HK, Dunn AK, Jones PB, et al. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain. 2007; 130(Pt 6): 1631-1642. doi: 10.1093/brain/awm071
Yuan Z, Liu W, Liu B, Schnell A, Liu KJ. Normobaric hyperoxia delays and attenuates early nitric oxide production in focal cere-bral ischemic rats. Brain Res. 2010; 1352: 248-254. doi: 10.1016/j. brainres.2010.07.010
Bennett M, Heard R. Hyperbaric oxygen therapy for mul-tiple sclerosis. CNS Neurosci Ther. 2010; 16(2): 115-124. doi: 10.1111/j.1755-5949.2009.00129.x
Zimmermann M. Ethical guidelines for investigations of ex-perimental pain in conscious animals. Pain. 1983; 16(2): 109-110. doi: 10.1016/0304-3959(83)90201-4
Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980; 20: 441-462. doi: 10.1146/an-nurev.pa.20.040180.002301
Pender MP, Nguyen KB, Willenborg DO. Demyelination and early remyelination in experimental allergic encephalomyelitis pas-sively transferred with myelin basic protein-sensitized lympho-cytes in the Lewis rat. J Neuroimmunol. 1989; 25(2-3): 125-142. doi: 10.1016/0165-5728(89)90130-6
Meeson AP, Piddlesden S, Morgan BP, Reynolds R. The dis-tribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis. Exp Neurol. 1994; 129(2): 299-310. doi: 10.1006/exnr.1994.1172
Larochelle C, Alvarez JI, Prat A. How do immune cells over-come the blood-brain barrier in multiple sclerosis? FEBS Lett. 2011; 585(23): 3770-3780. doi: 10.1016/j.febslet.2011.04.066
Guy J, Qi X, Hauswirth WW. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental al-lergic encephalomyelitis. Proc Natl Acad Sci U S A. 1998; 95(23): 13847-13852. doi: 10.1073/pnas.95.23.13847 Submit your article to this journal | https://openventio.org/submit-manuscript/
Hsieh HJ, Liu CA, Huang B, Tseng AH, Wang DL. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications. J Biomed Sci. 2014; 21(1): 3. doi: 10.1186/1423-0127-21-3
Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002; 1(4): 232-241. doi: 10.1016/s1474- 4422(02)00102-3
MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experi-mental autoimmune encephalomyelitis: enhancement by the solu-ble products of encephalitogenic T cells. J Exp Med. 1992; 176(1): 303-307. doi: 10.1084/jem.176.1.303
Schreibelt G, Musters RJ, Reijerkerk A, et al. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol. 2006; 177(4): 2630-2637. doi: 10.4049/jimmunol.177.4.2630
Hendriks JJ, de Vries HE, van der Pol SM, van den Berg TK, van Tol EA, Dijkstra CD. Flavonoids inhibit myelin phagocytosis by macrophages: A structure-activity relationship study. Biochem Phar-macol. 2003; 65(5): 877-885. doi: 10.1016/s0006-2952(02)01609-x
Nonaka Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. Combination effects of normobaric hyperoxia and edaravone on focal cerebral ischemia-induced neuronal damage in mice. Neurosci Lett. 2008; 441(2): 224-228. doi: 10.1016/j.neulet.2008.06.033
Eken A, Aydin A, Sayal A, Ustündağ A, Duydu Y, Dündar K. The effects of hyperbaric oxygen treatment on oxidative stress and SCE frequencies in humans. Clin Biochem. 2005; 38(12): 1133-1137. doi: 10.1016/j.clinbiochem.2005.09.001
Chiou HC, Huang SH, Hung CH, et al. Hyperbaric oxygen therapy alleviates the autoimmune encephalomyelitis via the reduc-tion of IL-17a and GM-Csf production of autoreactive T cells as well as boosting the immunosuppressive IL-10 in the central nervous system tissue lesions. Biomedicines. 2021; 9(8): 943. doi: 10.3390/biomedicines9080943
Anderson DC, Bottini AG, Jagiella WM, et al. A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke. 1991; 22(9): 1137-1142. doi: 10.1161/01.str.22.9.1137
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Sports and Exercise Medicine (SEM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
